26.06
price up icon1.01%   0.26
after-market アフターアワーズ: 26.06
loading
前日終値:
$25.80
開ける:
$26.19
24時間の取引高:
527.55K
Relative Volume:
0.40
時価総額:
$2.09B
収益:
-
当期純損益:
$-64.16M
株価収益率:
-20.52
EPS:
-1.2702
ネットキャッシュフロー:
$-69.06M
1週間 パフォーマンス:
-0.84%
1か月 パフォーマンス:
+2.44%
6か月 パフォーマンス:
-7.92%
1年 パフォーマンス:
-17.09%
1日の値動き範囲:
Value
$25.23
$26.56
1週間の範囲:
Value
$25.00
$26.59
52週間の値動き範囲:
Value
$14.80
$40.47

Cg Oncology Inc Stock (CGON) Company Profile

Name
名前
Cg Oncology Inc
Name
セクター
Healthcare (1170)
Name
電話
(949) 419-6203
Name
住所
400 SPECTRUM CENTER DRIVE, IRVINE
Name
職員
113
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
CGON's Discussions on Twitter

CGON を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CGON
Cg Oncology Inc
26.06 2.09B 0 -64.16M -69.06M -1.2702
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.82 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
520.29 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
321.82 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.53 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
267.12 28.51B 3.81B -644.79M -669.77M -6.24

Cg Oncology Inc Stock (CGON) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-02 開始されました JP Morgan Overweight
2025-04-16 開始されました Scotiabank Sector Perform
2025-01-07 開始されました TD Cowen Buy
2024-10-24 開始されました UBS Buy
2024-09-23 開始されました RBC Capital Mkts Outperform
2024-08-28 開始されました ROTH MKM Buy
2024-06-28 開始されました BofA Securities Buy
2024-02-20 開始されました Cantor Fitzgerald Overweight
2024-02-20 開始されました Goldman Neutral
2024-02-20 開始されました Morgan Stanley Overweight
2024-02-14 開始されました H.C. Wainwright Buy
すべてを表示

Cg Oncology Inc (CGON) 最新ニュース

pulisher
Jun 18, 2025

Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going - KamloopsBCNow

Jun 18, 2025
pulisher
Jun 18, 2025

Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going - Cantech Letter

Jun 18, 2025
pulisher
Jun 18, 2025

CG Oncology (NASDAQ:CGON) Price Target Raised to $56.00 at Morgan Stanley - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

Rhumbline Advisers Buys 5,673 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

CG Oncology (NASDAQ:CGON) Trading 4.7% Higher After Analyst Upgrade - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

CGON: Morgan Stanley Raises Price Target for CG Oncology | CGON Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

CG Oncology price target raised to $56 from $52 at Morgan Stanley - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

August 15th Options Now Available For CG Oncology (CGON) - Nasdaq

Jun 17, 2025
pulisher
Jun 16, 2025

Non-Muscle Invasive Bladder Cancer Market Set to Grow Substantially Through 2034, DelveInsight Projects | CG Oncology, Pfizer, UroGen Pharma, Janssen Research & Development, LLC, Protara Therapeutics - The Globe and Mail

Jun 16, 2025
pulisher
Jun 12, 2025

Cantor Fitzgerald Predicts CG Oncology FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

California State Teachers Retirement System Buys 20,763 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World

Jun 10, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Makes New Investment in CG Oncology, Inc. (NASDAQ:CGON) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Bluefield Daily Telegraph

Jun 05, 2025
pulisher
Jun 05, 2025

CG Oncology Brings Breakthrough Bladder Cancer Treatment to Goldman Sachs Healthcare Conference - Stock Titan

Jun 05, 2025
pulisher
Jun 04, 2025

Ameriprise Financial Inc. Grows Stock Holdings in CG Oncology, Inc. (NASDAQ:CGON) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Promising Market Position and Investment Opportunity: CG Oncology’s Creto in NMIBC Treatment - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

CG Oncology, Inc. (NASDAQ:CGON) Position Reduced by Nuveen Asset Management LLC - Defense World

Jun 02, 2025
pulisher
May 31, 2025

BNP Paribas Financial Markets Lowers Stake in CG Oncology, Inc. (NASDAQ:CGON) - Defense World

May 31, 2025
pulisher
May 29, 2025

CG Oncology, Inc. (NASDAQ:CGON) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

May 29, 2025
pulisher
May 27, 2025

CG Oncology’s SWOT analysis: bladder cancer treatment stock shows promise amid competition - Investing.com

May 27, 2025
pulisher
May 27, 2025

Bank of America Corp DE Has $6.01 Million Stake in CG Oncology, Inc. (NASDAQ:CGON) - Defense World

May 27, 2025
pulisher
May 27, 2025

Millennium Management LLC Invests $7.14 Million in CG Oncology, Inc. (NASDAQ:CGON) - Defense World

May 27, 2025
pulisher
May 27, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases 1,026 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World

May 27, 2025
pulisher
May 26, 2025

CGON Stock Rallies 27% in a Month on Bladder Cancer Study Success - MSN

May 26, 2025
pulisher
May 26, 2025

Deutsche Bank AG Acquires 13,589 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World

May 26, 2025
pulisher
May 20, 2025

CG Oncology (NASDAQ:CGON) Given New $52.00 Price Target at Morgan Stanley - Defense World

May 20, 2025
pulisher
May 19, 2025

CGON Stock Rating Maintained by Morgan Stanley Despite Price Target Cut | CGON Stock News - GuruFocus

May 19, 2025
pulisher
May 18, 2025

Cantor Fitzgerald Lowers Earnings Estimates for CG Oncology - Defense World

May 18, 2025
pulisher
May 17, 2025

CG Oncology, Inc. (NASDAQ:CGON) Position Boosted by Northern Trust Corp - Defense World

May 17, 2025
pulisher
May 16, 2025

Q2 Earnings Forecast for CG Oncology Issued By HC Wainwright - Defense World

May 16, 2025
pulisher
May 15, 2025

CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference - The Manila Times

May 15, 2025
pulisher
May 15, 2025

Leading Bladder Cancer Drug Developer CG Oncology Takes Stage at Major RBC Healthcare Conference - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Analysts Are Bullish on These NA Stocks: American Healthcare REIT, Inc. (AHR), CG Oncology, Inc. (CGON) - The Globe and Mail

May 15, 2025
pulisher
May 14, 2025

CG Oncology (NASDAQ:CGON) Shares Gap Down on Disappointing Earnings - Defense World

May 14, 2025
pulisher
May 14, 2025

Decoding CG Oncology Inc (CGON): A Strategic SWOT Insight - GuruFocus

May 14, 2025
pulisher
May 13, 2025

CG Oncology reports Q1 EPS (45c), consensus (37c) - TipRanks

May 13, 2025
pulisher
May 13, 2025

CGON Q1 Revenue Falls Short; Advances in Bladder Cancer Therapy - GuruFocus

May 13, 2025
pulisher
May 13, 2025

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates - ADVFN

May 13, 2025
pulisher
May 13, 2025

CG Oncology, Inc. (CGON) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

CG Oncology Q1 Loss Widens, Revenue Falls - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

CG Oncology, Inc. SEC 10-Q Report - TradingView

May 13, 2025
pulisher
May 13, 2025

CG Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 13, 2025
pulisher
May 06, 2025

Here Are Reasons Why Cg Oncology Inc (NASDAQ: CGON) Is A Great Choice Now - Stocksregister

May 06, 2025
pulisher
May 05, 2025

CG Oncology Jumps 25% on Positive Trial Results - Orange County Business Journal

May 05, 2025
pulisher
May 05, 2025

CG Oncology (NASDAQ:CGON) Earns Overweight Rating from Analysts at JPMorgan Chase & Co. - Defense World

May 05, 2025
pulisher
May 04, 2025

CG Oncology, Inc. (NASDAQ:CGON) Given Consensus Recommendation of “Buy” by Analysts - Defense World

May 04, 2025
pulisher
May 03, 2025

CG Oncology, Inc. (NASDAQ:CGON) Shares Purchased by Invesco Ltd. - Defense World

May 03, 2025
pulisher
May 02, 2025

CG Oncology initiated with an Overweight at JPMorgan - TipRanks

May 02, 2025
pulisher
May 02, 2025

CGON Stock: JP Morgan Initiates Coverage with Overweight Rating - GuruFocus

May 02, 2025
pulisher
May 02, 2025

JPMorgan Initiates Coverage on CG Oncology With Overweight Rating, $41 Price Target - marketscreener.com

May 02, 2025
pulisher
May 02, 2025

CGON: JPMorgan Starts Coverage with Overweight Rating and $41 Ta - GuruFocus

May 02, 2025

Cg Oncology Inc (CGON) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Cg Oncology Inc (CGON) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
POST LEONARD E
Director
May 21 '25
Sale
28.00
1,000
28,000
0
POST LEONARD E
Director
Apr 28 '25
Option Exercise
0.60
1,000
600
1,000
POST LEONARD E
Director
Apr 28 '25
Sale
30.76
1,000
30,760
0
POST LEONARD E
Director
Mar 17 '25
Option Exercise
0.60
1,000
600
1,000
POST LEONARD E
Director
Mar 17 '25
Sale
28.00
1,000
28,000
0
$20.52
price down icon 1.06%
$35.91
price down icon 0.64%
$21.27
price up icon 1.67%
$104.85
price down icon 0.99%
$104.80
price down icon 0.28%
biotechnology ONC
$267.12
price up icon 0.12%
大文字化:     |  ボリューム (24 時間):